\-\ Texto\\:\\ \ \(0\)\
\-\ right\\-sided\\ paralysis\\.\\ aao\\ x\\ 3\\.\\ no\\ labs\\.\ \(0\)\
\-\ this\\ patient\\ was\\ being\\ seen\\ by\\ the\\ neurology\\ service\\ and\\ receiving\\ intravenous\\ corticosteroids\\.\\ \\)\\.\ \(0\)\
\-\ \\â\\€\\¢\\ the\\ characteristics\\ dawson\\'s\\ fingers\\ are\\ the\\ classic\\ periventricular\\ white\\ matter\\ lesions\\ situated\\ perpendicular\\ to\\ the\\ ventricles\\ as\\ seen\\ in\\ this\\ patient\\'s\\ images\\.\ \(0\)\
\-\ \\â\\€\\¢\\ on\\ t2\\-flair\\ weighted\\ images\\,\\ the\\ plaques\\ are\\ hyperintense\\ compared\\ to\\ brain\\.\ \(0\)\
\-\ \\â\\€\\¢\\ the\\ perivascular\\ demyelination\\ gives\\ the\\ appearance\\ of\\ a\\ finger\\ pointing\\ along\\ the\\ axis\\ of\\ the\\ vessel\\.\\ in\\ the\\ pathologic\\ literature\\ these\\ elongated\\ lesions\\ have\\ been\\ named\\ \\"dawson\\'s\\ fingers\\.\\"\\ active\\ demyelination\\ is\\ accompanied\\ by\\ transient\\ breakdown\\ of\\ the\\ blood\\-brain\\ barrier\\.\\ there\\ are\\ chronic\\ lesions\\ that\\ demonstrate\\ gliosis\\.\ \(0\)\
\-\ multiple\\ sclerosis\ \(41\)\
\-\ multiple\\ sclerosis\ \(41\)\
\-\ white\\ matter\\ ischemia\\/white\\ matter\\ lesions\\ of\\ aging\ \(0\)\
\-\ progressive\\ multifocal\\ leukoencephalopathy\\(pml\\)\ \(0\)\
\-\ acute\\ disseminated\\ encephalomyelitis\\ \\(adem\\)\ \(0\)\
\-\ 45\\ year\\ old\\ man\\ with\\ a\\ long\\-standing\\ history\\ \\[witheld\\]\\ and\\ new\\ onset\\ of\\ acute\\ right\\-sided\\ hemiplegia\\.\ \(1\)\
\-\ this\\ patient\\ had\\ long\\ history\\ of\\ multiple\\ sclerosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ dawson\\:\\ 0\\.2637517810223199\ \(0\)\
\-\ demyelination\\:\\ 0\\.21333578038420373\ \(0\)\
\-\ lesions\\:\\ 0\\.2105893397005036\ \(0\)\
\-\ matter\\:\\ 0\\.20939797368512256\ \(0\)\
\-\ the\\:\\ 0\\.20120717099942664\ \(0\)\
\-\ fingers\\:\\ 0\\.19612399039945616\ \(0\)\
\-\ sclerosis\\:\\ 0\\.19588443232739666\ \(0\)\
\-\ white\\:\\ 0\\.1814445442067892\ \(0\)\
\-\ multiple\\:\\ 0\\.1345139232137623\ \(0\)\
\-\ aao\\:\\ 0\\.13187589051115994\ \(0\)\
\-\ pml\\:\\ 0\\.12646870819760678\ \(0\)\
\-\ witheld\\:\\ 0\\.12646870819760678\ \(0\)\
\-\ situated\\:\\ 0\\.12243003045888134\ \(0\)\
\-\ long\\:\\ 0\\.12157379249066111\ \(0\)\
\-\ named\\:\\ 0\\.11920520856496421\ \(0\)\
\-\ aging\\:\\ 0\\.11920520856496421\ \(0\)\
\-\ brain\\:\\ 0\\.11429413649060884\ \(0\)\
\-\ pointing\\:\\ 0\\.11422095114263832\ \(0\)\
\-\ breakdown\\:\\ 0\\.11422095114263832\ \(0\)\
\-\ perpendicular\\:\\ 0\\.11318380301552312\ \(0\)\
\-\ gliosis\\:\\ 0\\.11129100391378098\ \(0\)\
\-\ barrier\\:\\ 0\\.11042213186201429\ \(0\)\
\-\ leukoencephalopathy\\:\\ 0\\.11042213186201429\ \(0\)\
\-\ perivascular\\:\\ 0\\.10881376882908515\ \(0\)\
\-\ of\\:\\ 0\\.10763691711393611\ \(0\)\
\-\ encephalomyelitis\\:\\ 0\\.10735183248899939\ \(0\)\
\-\ gives\\:\\ 0\\.10666789019210186\ \(0\)\
\-\ paralysis\\:\\ 0\\.10601187182639529\ \(0\)\
\-\ hemiplegia\\:\\ 0\\.10601187182639529\ \(0\)\
\-\ are\\:\\ 0\\.10435421189142269\ \(0\)\
\-\ elongated\\:\\ 0\\.10362672993560547\ \(0\)\
\-\ accompanied\\:\\ 0\\.10015197736868063\ \(0\)\
\-\ corticosteroids\\:\\ 0\\.09928310531691392\ \(0\)\
\-\ disseminated\\:\\ 0\\.09928310531691392\ \(0\)\
\-\ acute\\:\\ 0\\.09918033375864412\ \(0\)\
\-\ adem\\:\\ 0\\.09845881087585884\ \(0\)\
\-\ neurology\\:\\ 0\\.09692715547476348\ \(0\)\
\-\ receiving\\:\\ 0\\.09519750719928895\ \(0\)\
\-\ service\\:\\ 0\\.09487284528129493\ \(0\)\
\-\ this\\:\\ 0\\.09449877272720524\ \(0\)\
\-\ periventricular\\:\\ 0\\.09424255985680652\ \(0\)\
\-\ plaques\\:\\ 0\\.0924877033905051\ \(0\)\
\-\ transient\\:\\ 0\\.09016958067846907\ \(0\)\
\-\ literature\\:\\ 0\\.08946566296774175\ \(0\)\
\-\ patient\\:\\ 0\\.08944731085061813\ \(0\)\
\-\ multifocal\\:\\ 0\\.08901295082358027\ \(0\)\
\-\ axis\\:\\ 0\\.08857264332562091\ \(0\)\
\-\ finger\\:\\ 0\\.08712015172183812\ \(0\)\
\-\ seen\\:\\ 0\\.08631533846333073\ \(0\)\
\-\ images\\:\\ 0\\.08480730095169502\ \(0\)\
\-\ characteristics\\:\\ 0\\.08405848065418858\ \(0\)\
\-\ intravenous\\:\\ 0\\.08357391474666029\ \(0\)\
\-\ ventricles\\:\\ 0\\.08053824201569337\ \(0\)\
\-\ vessel\\:\\ 0\\.08040705583120647\ \(0\)\
\-\ by\\:\\ 0\\.07785711378542663\ \(0\)\
\-\ pathologic\\:\\ 0\\.07511225312497107\ \(0\)\
\-\ compared\\:\\ 0\\.07411038540358907\ \(0\)\
\-\ 45\\:\\ 0\\.07350389009204193\ \(0\)\
\-\ hyperintense\\:\\ 0\\.07291945410908822\ \(0\)\
\-\ progressive\\:\\ 0\\.07020965030030439\ \(0\)\
\-\ history\\:\\ 0\\.07004677847420475\ \(0\)\
\-\ classic\\:\\ 0\\.06856504483234684\ \(0\)\
\-\ weighted\\:\\ 0\\.06837854117204188\ \(0\)\
\-\ active\\:\\ 0\\.06807243251955711\ \(0\)\
\-\ being\\:\\ 0\\.06387952241725431\ \(0\)\
\-\ labs\\:\\ 0\\.06351007583946239\ \(0\)\
\-\ new\\:\\ 0\\.0634190262001109\ \(0\)\
\-\ along\\:\\ 0\\.06141564023599141\ \(0\)\
\-\ onset\\:\\ 0\\.05886415130010383\ \(0\)\
\-\ appearance\\:\\ 0\\.05526451474056661\ \(0\)\
\-\ chronic\\:\\ 0\\.054412913209921525\ \(0\)\
\-\ been\\:\\ 0\\.053408197421477226\ \(0\)\
\-\ these\\:\\ 0\\.05176624496175651\ \(0\)\
\-\ man\\:\\ 0\\.048531433499321666\ \(0\)\
\-\ demonstrate\\:\\ 0\\.04765688593333142\ \(0\)\
\-\ to\\:\\ 0\\.04583482621530675\ \(0\)\
\-\ have\\:\\ 0\\.045794379429356394\ \(0\)\
\-\ had\\:\\ 0\\.04567355015067368\ \(0\)\
\-\ in\\:\\ 0\\.04560922729560219\ \(0\)\
\-\ that\\:\\ 0\\.03978150397154388\ \(0\)\
\-\ and\\:\\ 0\\.03788512040575839\ \(0\)\
\-\ as\\:\\ 0\\.036827242131218144\ \(0\)\
\-\ there\\:\\ 0\\.036475356802342325\ \(0\)\
\-\ was\\:\\ 0\\.03194803246634404\ \(0\)\
\-\ no\\:\\ 0\\.029810162110962157\ \(0\)\
\-\ year\\:\\ 0\\.02825100403173532\ \(0\)\
\-\ on\\:\\ 0\\.027686026053141327\ \(0\)\
\-\ old\\:\\ 0\\.027130743198200916\ \(0\)\
\-\ is\\:\\ 0\\.025104554373959424\ \(0\)\
\-\ with\\:\\ 0\\.017950205024377205\ \(0\)\
